Tasigna Chemotherapy

A healthcare provider may prescribe Tasigna® (nilotinib) to help treat a certain type of cancer called chronic myeloid leukemia (CML). It is only approved for use in people age 18 and older.
CML is a slowly progressing leukemia in which bone marrow stem cells (the early cells that form blood cells) develop into many abnormal granulocytes (a type of white blood cell). Some of these cells never become mature white blood cells (also called blasts). Over time, the granulocytes and blasts crowd out the red blood cells and platelets in the bone marrow.
As a chemotherapy drug, Tasigna works to treat CML by reducing the activity of a certain type of protein in the body that the cancer cells need to grow and multiply.
(For more details on this chemotherapy drug, click Tasigna. This Web selection explores this medicine in detail, including possible side effects, dosing guidelines, and safety precautions.)
5 Easy Tips to Manage Visitors During Cancer Treatment
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.